CMF-019

CMF-019 is a drug which is a selective, small-molecule agonist for the apelin receptor. It is used in research into treatment for heart failure.^[1][2][3]

CMF-019

Identifiers
IUPAC name (3S)-5-methyl-3-[[1-pentan-3-yl-2-(thiophen-2-ylmethyl)benzimidazole-5-carbonyl]amino]hexanoic acid
CAS Number	1586787-08-7
PubChem CID	73442763
Chemical and physical data
Formula	C25H33N3O3S
Molar mass	455.62 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCC(CC)N1C2=C(C=C(C=C2)C(=O)N[C@@H](CC(C)C)CC(=O)O)N=C1CC3=CC=CS3
InChI InChI=1S/C25H33N3O3S/c1-5-19(6-2)28-22-10-9-17(25(31)26-18(12-16(3)4)14-24(29)30)13-21(22)27-23(28)15-20-8-7-11-32-20/h7-11,13,16,18-19H,5-6,12,14-15H2,1-4H3,(H,26,31)(H,29,30)/t18-/m0/s1 Key:VCQKKZXFASLXAH-SFHVURJKSA-N

See also

• AM-8123
• Azelaprag
• BMS-986224